Cordis DX®
Cordis DX® A set of multi-gene assays with high sensitivity and specificity that have been clinically tested, Cordis DX® examines the genes linked to cardiovascular disorders, including: Arrhythmias Hypertrophic cardiomyopathy (HCM), distense cardiomyopathy (DCM), restrictive cardiomyopathy (RCM), and LVNC are examples of cardiomyopathies.
Dyslipidemias, including familial hypercholesterolemia, and hyperlipidemias Aortic Dissections and Aortic Disorders Hypertension of the Pulmonary Arteries Heart disease that is congenital Danlos-Ehlers syndrome The Marfan syndrome Short-QT and Long-QT Syndromes The Noonan syndrome The Brugada syndrome The syndrome known as Catecholaminergic Polymorphic Ventricular Tachycardia
The significance of Cordis DX® gene testing for cardiovascular illness With excellent sensitivity and specificity rates, CordisDX® genetic studies give the doctor the most differential diagnosis possible, saving them money and time on each patient case.
Diagnosis: Minimizes the need for more intrusive procedures by quickly and reliably confirming the clinical diagnosis. Genetic analysis has made it possible to accurately diagnose inherited cardiovascular disorders, reducing conundrums related to the prognosis and management of the condition and helping the doctor determine whether surgery is necessary. The test plays a significant role in the diagnosis of genetic arrhythmogenic disorders (also known as channelopathies or canalopathies) that present a high risk of sudden death in a heart with normal structure, such as Brugada syndrome, long QT syndrome, etc
Prognosis: By identifying the precise gene alterations causing a patient’s illness, we can forecast how it will develop while accounting for all relevant variables. Relatives who have the same mutation and are more likely to get the same illness can also be found and treated appropriately. The contribution of the test is especially significant in families with genes linked to sudden mortality. The accurate diagnosis and prognosis of the illness are the foundation for the right management of the patient and his family, which helps the doctor focus on the best course of action. provides lifestyle advice and information on avoiding certain prescriptions for Cordis DX®
Prevent heart attacks aids in the selection of early surgery and the implantation of a pacemaker or implanted cardiac defibrillator. identifies potential actions and suitable testing intervals for family members who are at risk.
A blood sample is used for Cordis DX® cardiovascular disease gene testing (2 vials of blood with EDTA).
CORDIS DX® The CordisDX® test examines 292 genes that have mutations associated with every potential hereditary cardiovascular condition.
Recommended from
- The European Society of Cardiology and the European Respiratory Society have recommended the following international guidelines for the diagnosis and treatment of pulmonary hypertension: FAMILY, HISTORY, TABLE, TABLE, and International Guidelines.
- The Heart Rhythm Society (HRS) and European Heart Rhythm Association
- The American Association of Cardiologists for the diagnosis and treatment of arrhythmias.
- the Heart Failure Society of America and the European Society of Cardiology for the diagnosis and treatment of cardiomyopathy;
- and the European Heart Radiological Association (EHRA) for the diagnosis and treatment of channelopathies.


